Feb 23, 2026 09:36AM
Feb 23, 2026 08:09AM
Feb 23, 2026 06:01AM
Feb 23, 2026 06:01AM
Feb 4, 2026 09:01AM
Feb 4, 2026 09:00AM
Jan 21, 2026 04:00PM Arcellx presents anito-cel research at 2026 Tandem Meetings
Jan 21, 2026 04:00PM
Dec 8, 2025 02:54AM
Dec 6, 2025 02:00PM
Nov 3, 2025 09:00AM
Aug 7, 2025 04:00PM
Jul 31, 2025 07:08AM
May 14, 2025 09:30AM Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma
May 8, 2025 04:00PM
Mar 20, 2025 04:00PM
Mar 20, 2025 04:00PM
Feb 27, 2025 04:00PM
Jan 2, 2025 04:00PM
Dec 8, 2024 11:00PM
Nov 7, 2024 04:00PM Arcellx Provides Third Quarter 2024 Financial Results and Business Highlights
Nov 6, 2024 07:23AM
Nov 5, 2024 09:01AM
Nov 5, 2024 09:00AM
Aug 8, 2024 04:00PM
May 9, 2024 04:08PM
May 9, 2024 04:05PM
May 9, 2024 04:05PM Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
May 9, 2024 04:00PM
May 7, 2024 04:00PM
Apr 4, 2024 04:00PM
Mar 20, 2024 04:00PM
Mar 18, 2024 11:59AM
Feb 29, 2024 04:00PM
Feb 28, 2024 04:00PM Arcellx Provides Fourth Quarter and Year-End 2023 Financial Results and Business Highlights
Dec 8, 2023 04:02PM
Dec 8, 2023 04:00PM
Nov 15, 2023 06:00AM
Nov 15, 2023 06:00AM
Nov 15, 2023 06:00AM
Nov 13, 2023 04:00PM
Nov 2, 2023 09:00AM Arcellx Announces Oral Presentation for Its CART-ddBCMA Phase 1 Trial in Patients with Relapsed or Refractory Multiple Myeloma at the 65th ASH Annual Meeting and Exposition
Oct 26, 2023 04:00PM
Aug 14, 2023 04:00PM
Aug 14, 2023 04:00PM
Jun 20, 2023 06:53AM
Jun 20, 2023 06:09AM
Jun 19, 2023 07:46PM
May 8, 2023 04:00PM Arcellx Provides First Quarter Financial Results
Apr 13, 2023 04:01PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All